Siedlak S - Search Results

1

Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.

Wang Z, Becker K, Donadio V, Siedlak S, Yuan J, Rezaee M, Incensi A, Kuzkina A, Orrú CD, Tatsuoka C, Liguori R, Gunzler SA, Caughey B, Jimenez-Capdeville ME, Zhu X, Doppler K, Cui L, Chen SG, Ma J, Zou WQ. Wang Z, et al. Among authors: siedlak s. JAMA Neurol. 2020 Sep 28;78(1):1-11. doi: 10.1001/jamaneurol.2020.3311. Online ahead of print. JAMA Neurol. 2020. PMID: 32986090 Free PMC article.

2

The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau.

Hartzler AW, Zhu X, Siedlak SL, Castellani RJ, Avilá J, Perry G, Smith MA. Hartzler AW, et al. Neurobiol Aging. 2002 Sep-Oct;23(5):855-9. doi: 10.1016/s0197-4580(02)00029-5. Neurobiol Aging. 2002. PMID: 12392790

3

Distribution, levels, and activation of MEK1 in Alzheimer's disease.

Zhu X, Sun Z, Lee HG, Siedlak SL, Perry G, Smith MA. Zhu X, et al. J Neurochem. 2003 Jul;86(1):136-42. doi: 10.1046/j.1471-4159.2003.01820.x. J Neurochem. 2003. PMID: 12807433 Free article.

4

Oxidative stress mechanisms and potential therapeutics in Alzheimer disease.

Moreira PI, Siedlak SL, Aliev G, Zhu X, Cash AD, Smith MA, Perry G. Moreira PI, et al. Among authors: siedlak sl. J Neural Transm (Vienna). 2005 Jul;112(7):921-32. doi: 10.1007/s00702-004-0242-8. Epub 2004 Dec 7. J Neural Transm (Vienna). 2005. PMID: 15583960 Review.

5

Compensatory responses induced by oxidative stress in Alzheimer disease.

Moreira PI, Zhu X, Liu Q, Honda K, Siedlak SL, Harris PL, Smith MA, Perry G. Moreira PI, et al. Biol Res. 2006;39(1):7-13. doi: 10.4067/s0716-97602006000100002. Biol Res. 2006. PMID: 16629160 Free article. Review.

6

LRRK2 protein is a component of Lewy bodies.

Zhu X, Siedlak SL, Smith MA, Perry G, Chen SG. Zhu X, et al. Ann Neurol. 2006 Nov;60(5):617-618. doi: 10.1002/ana.20928. Ann Neurol. 2006. PMID: 16847950 No abstract available.

7

Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions.

Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G, Aliev G. Obrenovich ME, et al. Neurotox Res. 2006 Aug;10(1):43-56. doi: 10.1007/BF03033333. Neurotox Res. 2006. PMID: 17000469

8

Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease.

Mei M, Su B, Harrison K, Chao M, Siedlak SL, Previll LA, Jackson L, Cai DX, Zhu X. Mei M, et al. J Neurochem. 2006 Dec;99(5):1377-88. doi: 10.1111/j.1471-4159.2006.04174.x. Epub 2006 Oct 25. J Neurochem. 2006. PMID: 17064357 Free article.

9

LRRK2 in Parkinson's disease and dementia with Lewy bodies.

Zhu X, Babar A, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Perry G, Chen SG. Zhu X, et al. Mol Neurodegener. 2006 Nov 30;1:17. doi: 10.1186/1750-1326-1-17. Mol Neurodegener. 2006. PMID: 17137507 Free PMC article.

10

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease.

Casadesus G, Smith MA, Basu S, Hua J, Capobianco DE, Siedlak SL, Zhu X, Perry G. Casadesus G, et al. Among authors: siedlak sl. Mol Neurodegener. 2007 Jan 22;2:2. doi: 10.1186/1750-1326-2-2. Mol Neurodegener. 2007. PMID: 17241462 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page